David P Kanios

Title: Innovator Spotlight: David P Kanios - Revolutionizing Transdermal Drug Delivery

Introduction

David P Kanios, based in Miami, FL, is a distinguished inventor with a passion for advancing drug delivery technologies. With an impressive portfolio of 26 patents, David's innovative work in transdermal drug delivery systems has reshaped the pharmaceutical industry.

Latest Patents

1. Transdermal drug delivery device including an occlusive backing: This patent introduces a transdermal drug delivery system that optimizes the application of active agents through polymeric and adhesive carrier layers. The inclusion of a non-drug containing polymeric backing layer allows for precise control over the delivery rate and profile, enhancing the efficacy of transdermal drug delivery.

2. Device for transdermal administration of drugs including acrylic based polymers: David's groundbreaking invention leverages acrylic-based polymers to regulate the drug delivery rates, onset, and profiles of active agents in transdermal drug delivery systems. By strategically adjusting the monomeric composition of the acrylic-based polymer, this device ensures optimal solubility of the active agent and customized control over drug delivery characteristics.

Career Highlights

David P Kanios has made significant contributions to leading pharmaceutical companies, including Noven Pharmaceuticals, Inc. and Dow Corning Corporation. His expertise and dedication to innovation have influenced cutting-edge developments in drug delivery mechanisms, positioning him as a visionary in the field.

Collaborations

Throughout his career, David has collaborated with esteemed professionals in the industry, such as Juan A Mantelle and David Houze. Together, they have worked on pioneering projects that have pushed the boundaries of transdermal drug delivery technology, fostering a culture of innovation and collaboration.

Conclusion

In conclusion, David P Kanios stands as a trailblazer in the realm of transdermal drug delivery, with a remarkable track record of patents and contributions to the field. His inventive spirit, combined with his industry expertise, continues to drive advancements in pharmaceutical technologies, ultimately improving patient outcomes and revolutionizing drug delivery methods.